Department of Rheumatology, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia; and Medical School, Pontificia Universidad Javeriana, Bogotá, Colombia.
Dermatology Unit, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia; and Medical School, Pontificia Universidad Javeriana, Bogotá, Colombia.
Skinmed. 2021 Oct 1;19(5):369-373. eCollection 2021.
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease, with a low prevalence worldwide. There is little epidemiologic information available on this disease in Latin America, including Colombia. The aim of this study was to estimate the prevalence and describe the main demographic characteristics of HS in Colombia. This was a cross-sectional descriptive study using the code of the International Classification of Diseases (ICD-10) for HS (L732). For this study, data from the Comprehensive Social Protection Information System of the Ministry of Health of Colombia, which is the database on diagnoses made by physicians in all medical institutions of the country, were analyzed for the period 2013-2017. A total of 3,667 patients of HS were reported in Colombia, with a prevalence of 7.4/100,000 inhabitants; 68% of the patients affected were women, with a woman to man ratio of 2.1:1. The highest prevalence was in the age group of 35-39 years. Among the departments of Colombia, the highest prevalence was in Caldas, with 17 patients per 100,000 inhabitants. Ours was the second study conducted in Latin America on the epidemiology of HS. We found a low prevalence of HS, which was even lower than that reported in studies from other countries.
化脓性汗腺炎(HS)是一种慢性炎症性皮肤病,全球发病率较低。关于这种疾病在拉丁美洲,包括哥伦比亚的流行病学信息很少。本研究的目的是估计 HS 在哥伦比亚的流行率并描述其主要人口统计学特征。这是一项使用国际疾病分类(ICD-10)HS 代码(L732)的横断面描述性研究。在这项研究中,分析了哥伦比亚卫生部综合社会保护信息系统的数据,该系统是全国所有医疗机构医生诊断的数据库,时间范围为 2013 年至 2017 年。哥伦比亚共报告了 3667 例 HS 患者,患病率为 7.4/100,000 居民;68%的患者为女性,男女比例为 2.1:1。患病率最高的年龄段为 35-39 岁。在哥伦比亚的各个省份中,卡利省的患病率最高,为每 10 万人中有 17 例患者。我们的研究是拉丁美洲开展的第二项关于 HS 流行病学的研究。我们发现 HS 的患病率较低,甚至低于其他国家的报告。